期刊文献+

血液滤过在急性重症胰腺炎治疗中的应用 被引量:5

Application of Blood Filteration in Treatment of Severe Acute Pancreatitis
下载PDF
导出
摘要 目的探讨连续性静脉-静脉血液滤过(CVVH)在重症急性胰腺炎(SAP)治疗中的应用。方法回顾性分析25例SAP患者,采用常规综合治疗的同时行CVVH,观察临床症状、治疗前后APACHEII评分及血生化指标的变化。结果CVVH治疗过程中,25例SAP患者呼吸窘迫、烦躁、谵妄、腹痛、腹胀等症状逐渐缓解;与治疗前比较,治疗后APACHEII评分差异有显著性(P<0.05);25例SAP患者经CVVH治疗24h后,血总胆红素(TB)、AST、AMS、APS均明显降低,与治疗前比较差异具有显著性(P<0.05)。结论SAP患者早期及时、有效行CVVH等综合治疗,能有效缓解临床症状、改善生化指标、有助于维持水、电解质、酸碱平衡、内环境以及微循环稳定、改善心、肺、肾功能,是安全、有效的治疗措施之一。 Objective To discuss the application of continuous vein-vein blood filteration(CVVH) in treatment of severe acute pancreatitis (SAP). Methods The data of 25 SAP patients were analyized retrospectively. CVVH was used based on conventional comprehensive therapy, clinical symptoms, APACHEII scores and the blood biochemistry index changes were observed. Results During the CVVH course of treatment, the symptoms of 25 SAP patients such asrespiratory distress, dysphoria, delirium, abdominal pain and abdominal distension alleviated gradually; Compared with before the treatment, the APACHEII scores after the treatment had significant difference(P〈O.OS). Blood total bilirubin(TB),AST, AMS and APS of 25 SAP patients obviously reduced after 24 hours treatment, there was significant difference compared with before the treatment(P〈0.05). Conclusion Early, prompt, effective treatment of CVVH on SAP patients can alleviate the clinical symptoms effectively, improve biochemistry index, is helpful to maintain the stability of water, the electrolyte, the acid-base equilibrium and internal environment, improve the function of heart, lungs and kidney. It is safe and effective treatment measures.
作者 闫新
出处 《中国现代医生》 2009年第20期10-11,共2页 China Modern Doctor
关键词 SAP CVVH APACHEII评分 血生化指标 SAP CVVH APACHEII scores Blood biochemical index
  • 相关文献

参考文献8

二级参考文献43

  • 1杜智.血液净化在重症胰腺炎治疗中的作用[J].生物医学工程与临床,1999,3(2):63-67. 被引量:1
  • 2王建承,赵小团,袁祖荣,姜志宏,张臣烈,张圣道.肿瘤坏死因子在急性胰腺炎及并发多器官衰竭中作用的研究[J].中华医学杂志,1995,75(3):133-135. 被引量:14
  • 3张圣道 袁祖荣 等.重症急性胰腺炎诊治规范建议初稿.第七届全国胰腺外科学术研讨会论文汇编[M].成都,1998.11-13.
  • 4中华医学会外科分会胰腺外科学组.泰安:第四次全国胰腺外科学术会议摘要汇编[M].,1992,1..
  • 5[1]Hirassawa H, Sugai T, Oda S, et al. Continous hemodiafiltration can remove humoral mediators from the blood stream of patients with SIRS/MODS. Abstr. Blood Purif,1997, 15:136
  • 6[2]Heering P, Morgera S, Schmitz G, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med, 1997, 23:288
  • 7[3]Kouche K,Cavadore P,Portales P, et al. Continous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Neprol, 2002, 15:150
  • 8[4]Sander A,Armbruster W,Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but not alter IL-6 and TNF-α plasma concentrations. Intensive Care Med, 1997, 23:878
  • 9[6]Sieberth HG,Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int. 1999, 56(Suppl. 72): S79
  • 10[7]Silvester W. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 1997, 30 (Suppl.4): S38

共引文献653

同被引文献28

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部